Jade Biosciences (JBIO) Return on Equity (2021 - 2026)

Jade Biosciences (JBIO) has 6 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity fell 2.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (down 2.0% YoY), and the FY2025 full-year result was 0.0%, up 2.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 0.03% in Q4 2024 and bottomed at 0.02% in Q2 2025.
• The 5-year median for Return on Equity is 0.0% (2022), against an average of 0.0%.
• The widest annual swing landed in 2024, when Return on Equity increased 3 bps; it then fell 3 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then declined by 24 bps to 0.0% in 2023, then soared by 3288 bps to 0.03% in 2024, then slumped by 118 bps to 0.0% in 2025, then grew by 17 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.

Peer Comparison